Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan Cilexetil in Hypertensive Pediatric Subjects (6-17 Years)
NCT00244595Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2003
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of candesartan cilexetil in hypertension (HTN), sponsored by AstraZeneca. Started Sep 2003; status: completed.
02
Drugs
candesartan cilexetil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00244595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00244595.